Intravesical oncolytic therapy for bladder cancer
Ended Project Grant Awarded Last action
- Award ID
- R44CA221461
- Recipient
-
Vyriad Inc. UEI P4J2W42KVHQ7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,990,950
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Rochester, MN 55902, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $909,357 | |
| Amendment | $0 | |
| Amendment | $45,221 | |
| Amendment | -$45,221 | |
| Amendment | $924,838 | |
| Original award | $156,755 |
Show all 17
Quick answers
Who received award R44CA221461?
R44CA221461 was awarded to Vyriad Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2017.
How much is award R44CA221461 worth?
$1,990,950 has been obligated on R44CA221461.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award